Jaguar Animal Health (NASDAQ:JAGX) Stock Lifted to “Sell” by Wall Street Zen

Wall Street Zen upgraded shares of Jaguar Animal Health (NASDAQ:JAGX – Free Report) to a sell rating in a research report sent to investors on Saturday morning,Wall Street Zen reports.

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Jaguar Animal Health in a report on Friday, July 17th. One research analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, Jaguar Animal Health has a consensus rating of “Sell”.

Read Our Latest Stock Report on JAGX

Jaguar Animal Health Trading Up 5.7%

Shares of NASDAQ JAGX opened at $4.79 on Friday. The firm’s 50 day moving average price is $9.58 and its 200-day moving average price is $60.25. Jaguar Animal Health has a 52-week low of $2.35 and a 52-week high of $1,260.00. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.40 and a current ratio of 0.69. The company has a market cap of $1.63 million, a PE ratio of -0.00 and a beta of -0.11.

Jaguar Animal Health (NASDAQ:JAGX – Get Free Report) last announced its quarterly earnings results on Wednesday, August 19th. The biotechnology company reported ($15.70) earnings per share for the quarter, beating the consensus estimate of ($782.25) by $766.55. The firm had revenue of $1.23 million for the quarter, compared to the consensus estimate of $4.24 million.

Jaguar Animal Health Company Profile

(Get Free Report)

Jaguar Animal Health, Inc is a commercial-stage animal health company focused on developing and marketing products for gastrointestinal disorders in companion and production animals. Its research is centered on plant-based medicines, including products derived from the red-barked croton tree, Croton lechleri, traditionally used in South America.

The company’s lead animal health product is Canalevia-CA1, a prescription drug containing crofelemer that received conditional approval from the U.S.

See Also

Receive News & Ratings for Jaguar Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.